WHO Warns Against Obesity Drugs for Young Children as Gene Therapy Offers New Hope for Blind Patients

Two major health developments emerged Wednesday, as the World Health Organization issued new global guidelines on childhood obesity treatment and researchers revealed a breakthrough gene therapy capable of partially restoring sight in blind people.

The World Health Organization released new global guidelines Wednesday cautioning against the use of obesity drugs, including weight-loss injections, for children under the age of 10, according to BBC News. The guidelines emphasize that care for young children struggling with obesity should center on healthy eating and regular physical exercise rather than pharmaceutical interventions.

The WHO's position marks a significant stance amid the rapid global expansion of weight-loss medications, which have grown increasingly popular among adults in recent years. According to BBC News, the organization's recommendations draw a clear boundary for younger children, signaling that medical professionals and caregivers should prioritize lifestyle-based approaches over drug treatments for this age group. The guidelines offer a framework intended to guide health systems worldwide in managing what has become a growing public health concern affecting children across multiple continents, including across Africa.

In a separate but equally significant development, researchers revealed Wednesday that a type of gene therapy based on Nobel prize-winning science has proven safe and capable of partially restoring sight in blind people, according to The Guardian. The approach, known as optogenetic therapy, works by harnessing a technique that turns nerve cells on and off using light – the same science that earned researchers the 2026 Nobel Prize in Physiology or Medicine earlier this month, The Guardian reported. The findings represent a potentially transformative step forward for individuals living with blindness, offering a scientifically grounded pathway toward partial vision restoration.

Optogenetic therapy's recognition through the Nobel Prize underscores the broader scientific community's confidence in the approach, according to The Guardian. The therapy's confirmation as both safe and effective in human subjects marks a critical milestone in translating laboratory science into real-world medical treatment. For regions such as sub-Saharan Africa, where access to eye care remains limited and rates of preventable and untreatable blindness remain disproportionately high, such advances could carry significant long-term implications if made accessible.

Together, Wednesday's developments highlight the dual challenges facing global health systems: managing the rise of chronic conditions such as childhood obesity through evidence-based, non-pharmaceutical care, while simultaneously advancing cutting-edge therapies that could address conditions previously considered untreatable. Both the WHO guidelines and the optogenetic therapy research reflect a broader push within the international health community toward interventions grounded in rigorous science. As these developments continue to unfold, their relevance for African health policy and medical practice will likely draw increasing attention from governments, researchers, and public health advocates across the continent.

*Sources: BBC News, The Guardian*